Price-to-Projected Revenue Ratio: Huron (HURN)

Huron Consulting - graphic logo of issuer HURN

This forward price-to-sales ratio allows for an assessment of Huron Consulting Group (HURN) capitalization through the lens of cloud IT infrastructure and an asset-light model. Expertise in managing US government agencies strengthens market positioning, while long-term contracts ensure a stable cash flow. The value 1.00 reflects the latest metric reading, helping investors track the dynamics of discounting future sales and mitigate risks during market corrections.

HURN Huron: Market Cap to Projected Revenue in the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Huron Corp (HURN)

- current price and projected stock value:
- company stock exchange capitalization indicators:
Summary company analytics:Huron (HURN)
Manufactured products of Huron Consulting Group

The forward P/S reflects the ratio of Huron Consulting Group (HURN) current market value to expected sales, reacting promptly to revisions in financial forecasts. This indicator measures the business's margin of safety, showing the extent to which the market is willing to pay a premium for future revenues from the implementation of AI platforms in healthcare, which this forward price-to-sales chart clearly details.

Competing companies

Forward P/S Multiple VEEV (Veeva)|DOCS - Forward Price-to-Revenue Multiple|HQY - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Waystar Corp|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue PRVA|Price-to-Projected Revenue Ratio Certara|Omnicell Inc (OMCL) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple GDRX (GoodRx Corp)|Forward P/S Multiple Schrodinger Corp (SDGR)|Price-to-Projected Revenue Ratio Phreesia, Inc. PHR|omadahealth.com - Price-to-Projected Revenue Ratio|EVH: Forward Price-to-Revenue Multiple|HealthStream Inc - Price to Expected Revenue Ratio|DH: Forward P/S Multiple|CCSI - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Agilon Health|Market Cap to Projected Revenue ABSI (absci.com)|Forward P/S Multiple SY|NRC Health (NRC) - Projected Price to Revenue|Spok Corp - Forward Price-to-Revenue Multiple|Forward Price to Sales OPRX|TruBridge, Inc. - Forward P/S Multiple|Projected Price to Revenue simulations-plus.com (SLP)|sophiagenetics.com (SOPH) - Price-to-Projected Revenue Ratio|Health Catalyst Inc. - Forward Price to Sales|Price-to-Projected Revenue Ratio CareCloud Inc.|Market Cap to Future Revenue Ratio Research Solutions Inc. RSSS|Forward Price-to-Revenue Multiple DLHC (DLH Holdings Corp.)|Forward P/S Multiple onemednet.com (ONMD)|Price-to-Projected Revenue Ratio Scienture SCNX|HCTI (Healthcare Triangle Inc) - Future Price to Revenue|iSpecimen Corp - Forward P/S Multiple|Forward Price to Sales BFRG (Bullfrog AI Holdings)|WORX (SCWorx Corp.) - Forward Price-to-Revenue Multiple|msprecovery.com (MSPR) - Forward P/S Multiple|Price-to-Projected Revenue Ratio iCoreConnect, Inc.|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|r1rcm.com - Market Cap to Projected Revenue|Forward P/S Multiple SHCR (Sharecare, Inc.)|Market Cap to Expected Sales Ratio streamlinehealth.net (STRM)|SYRA: Forward Price-to-Revenue Multiple|Apollo Medical Holdings - Price to Expected Revenue Ratio|MODN (Model N Corp) - Forward Price-to-Revenue Multiple|NextGen Healthcare Corp - Forward Price to Sales